Macerich's moves to improve its portfolio quality were necessary
Analysts are decreasing fair value estimate to $29.50 per share from $32.50 per share after incorporating fourth-quarter results and adjusting our assumptions for the impact of the coronavirus.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。